Multiple functions of HMGB1 in cancer

被引:2
|
作者
Lv, Guangyao [1 ]
Yang, Menglin [2 ]
Gai, Keke [1 ]
Jia, Qiong [1 ]
Wang, Zhenzhen [1 ]
Wang, Bin [1 ]
Li, Xueying [3 ]
机构
[1] Binzhou Med Univ Hosp, Dept Pharm, Binzhou, Shandong, Peoples R China
[2] Marine Biomed Res Inst Qingdao, Qual Management Dept, Qingdao, Peoples R China
[3] Binzhou Polytech, Sch Hlth, Binzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
HMGB1; cancer; chemotherapy resistance; autophagy; immunotherapy; GROUP BOX 1; IMMUNOGENIC CELL-DEATH; HMGB1-MEDIATED AUTOPHAGY; PROTEIN HMGB1; ANGIOGENESIS; CHEMOTHERAPY; RESISTANCE; EXPRESSION; PROGRESSION; MIGRATION;
D O I
10.3389/fonc.2024.1384109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [21] HMGB1: A Promising Therapeutic Target for Prostate Cancer
    Gnanasekar, Munirathinam
    Kalyanasundaram, Ramaswamy
    Zheng, Guoxing
    Chen, Aoshuang
    Bosland, Maarten C.
    Kajdacsy-Balla, Andre
    PROSTATE CANCER, 2013, 2013
  • [22] Different measures of HMGB1 location in cancer immunology
    Gorgulho, Carolina Mendonca
    Murthy, Pranav
    Liotta, Lance
    Espina, Virginia
    Lotze, Michael T.
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - MOLECULAR METHODS, 2019, 629 : 195 - 217
  • [23] HMGB1 release in the cardiac niche: Interplay between HMGB1 and thrombin
    Bosakhar, Zainab
    Mackenzie, Graeme
    Gu, Hui
    Currie, Susan
    Cunningham, Margaret
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 140 - 140
  • [24] HMGB1 regulates pancreatic cancer initiation and pogression
    Kang, Rui
    Zhang, Qiuhong
    Hou, Wen
    Chen, Ruochan
    Lotze, Michael
    Zeh, Herbert
    Tang, Daolin
    CANCER RESEARCH, 2014, 74 (19)
  • [26] HMGB1-binding heptamer suppresses the synergistic effect of HMGB1 and LPS by interacting directly with HMGB1
    Kim, Il-Doo
    Luo, Lidan
    Lee, Hahn-bie
    Lee, Hye-Kyung
    Lee, Ja-Kyeong
    NEUROSCIENCE LETTERS, 2015, 593 : 40 - 44
  • [27] Mechansims of HMGB1 release
    Pisetsky, D. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 49 - 50
  • [28] HMGB1 in kidney diseases
    Zhao, Zhi
    Hu, Zhizhi
    Zeng, Rui
    Yao, Ying
    LIFE SCIENCES, 2020, 259
  • [29] HMGB1 in health and disease
    Kang, Rui
    Chen, Ruochan
    Zhang, Qiuhong
    Hou, Wen
    Wu, Sha
    Cao, Lizhi
    Huang, Jin
    Yu, Yan
    Fan, Xue-gong
    Yan, Zhengwen
    Sun, Xiaofang
    Wang, Haichao
    Wang, Qingde
    Tsung, Allan
    Billiar, Timothy R.
    Zeh, Herbert J., III
    Lotze, Michael T.
    Tang, Daolin
    MOLECULAR ASPECTS OF MEDICINE, 2014, 40 : 1 - 116
  • [30] HMGB1 and tumor immunology
    Lotze, MT
    SHOCK, 2004, 21 : 36 - 36